Takeda China announced on March 31 that Wang Rui will join Takeda China as the head of the digestion and marketing
The topic of relocation of chemical companies caused fermentation again
Time of Update: 2021-03-30
Committee of the 12th National People’s Congress held on August 30, 2015 The group meeting revealed that after the "8·12" accident in Tianjin, more than 1,000 chemical companies were reported to be relocated and reformed nationwide, and the total
The safety standardization system is launched
Time of Update: 2021-03-30
safety standardization information system-the State Administration of Work Safety recently issued "About the use of hazardous chemicals "Notice on the Work Safety Standardization Information Management System of Employed Units" requires local safety
Eight tasks for industry leaders in 2019
Time of Update: 2021-03-29
The meeting pointed out that in 2018, the added value of industrial enterprises above designated size is expected to increase by about 6.
More than 7,700 hospitals in my country have established an appointment diagnosis and treatment system
Time of Update: 2021-03-26
Medical Network News on March 24, National Health Commission’s Planning Development
Hengrui pharmaceutical hydrochloric acid right metomide injection was evaluated by generic consistency
Time of Update: 2021-03-10
the Evaluate Pharma database, the global sales of hydrochloric acid right metomide injections in 2019 are approximately $419 million.
Sudden! The general manager of a multinational pharmaceutical company in China has left his appointment
Time of Update: 2021-03-09
Sammy Karam, Abbott's senior vice president and head of emerging markets for the pharmaceutical business, announced the news to employees that Mr Kim would leave Abbott to seek other career opportunities, with the last working day on March 5.
Review: China's paint market development in 2014 presents three kinds of situations
Time of Update: 2021-03-09
by 0.6 percentage points. Residential investment accounted for 67.8% of real estate development investment. review of the overall trend of domestic real estate industry investment in 2014, we issued in 2014 China's real estate industry
Meikang Bio plans to raise an additional 600 million yuan for in-body diagnostic product development
Time of Update: 2021-03-08
Meikang Biotech Co., Ltd. ("Meikang Bio" or "Company") issues no more than 103,590,786 shares to no more than 35 specific subjects, raising a total of not more than $60,000.00 million. After deducting the issuance expenses, it is intended
Supplies national mining platform national unity, covering to the province
Time of Update: 2021-02-28
/> At present, 14 business subsystems of the platform have completed the initial inspection and entered the trial run stage. Among them, pharmaceutical, medical supplies tender procurement as the main function of medical security, will rely
Lepu Medical: The results of the mid-to-long-term business layout are bright and fruitful
Time of Update: 2021-02-27
due to the adjustment of short-term distribution mode, and surgical instruments such as matching devices achieved operating income of 130 million yuan, up 41.75% YoY, the market share further increased. in the research product layout is rich
The technological revolution in the field of pharmaceutical circulation will upend tradition
Time of Update: 2021-02-16
2017 is also a year of marketing model transformation, many pharmaceutical circulation enterprises (especially to do generic drug sales) set up their own sales control varieties team, from rough distribution and distribution to terminal customer service.
Con Caixin | Bio IPO has filed for registration with Abbott's global sales of $34.6 billion
Time of Update: 2021-02-10
